During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues. Register Now!
Patient engagement is essential in R&D and disease management. Many life science companies talk about yet are still searching for ways to deliver on their patient-centric missions. This webinar presents a proven model to embed patient-centricity into your company’s DNA. Register Now.
The market for orally disintegrating tablets (ODT) has grown annually and is projected to reach US$21B in 2023. Attend this complimentary webinar on patient-centric drug development and advanced ODT technologies in Japan and the US. Register now!
Join this webinar to discover the advantages of using Signatera™ (RUO), a novel assay custom-designed for each patient that detects circulating tumor DNA (ctDNA) with high sensitivity and specificity to monitor molecular residual disease, early recurrence, and treatment response across solid tumors. Register Now!
In this webinar, we will review the current OTC remedies for cough, cold and allergy categories and discuss strategies to grow your share on shelf space with innovative dosage forms.
Technology is impacting every aspect of our lives, and the life sciences industry is no different—it is changing the way companies operate. The need to embrace change is an imperative for these companies to stay competitive and continue to deliver on patient needs. Register Now!
To achieve adaptable and scalable trial execution, a mindset change and more flexible approach to data management is necessary. Join this webinar to hear industry experts discuss three key lessons learned when applying Agile Development Methodology principles into your work in data management.
Join Dr. David Gosalvez to see how R&D productivity can be improved in three critical areas: Lead Discovery, Screening and data capture. Register Now!
Learn how today’s market intelligence leaders leverage AI-powered tools to uncover relevant regulatory and M&A data, track emerging trends in healthcare, and drive strategic decisions to stay one step ahead of the competition.
Many patients take their medication inconsistently or incorrectly, which reduces effectiveness, increases safety risks, and causes billions of dollars in avoidable healthcare costs each year. Unit dose solutions help increase patient adherence by providing patients an accurate dose every time, increasing safety and patient compliance. Download the whitepaper now.
Learn how companies use the cloud to optimize clinical trial designs and analyze real-world data and how cloud-based artificial intelligence and machine learning are clearing the patient enrollment bottleneck. Download this whitepaper.
Serialization is a great achievement for our industry. However, most executives now realize that it is only part of the solution and serialization alone cannot solve the escalating problems of counterfeiting and diversion within the Pharmaceutical industry.
In this webinar we will discuss going beyond serialization and understanding why it’s not enough and the need to stay innovative and add value and protection to your current solutions. Register now.
This whitepaper explores a foundational health informatics platform for the clinical trials ecosystem enabling researchers to use real-world data from healthcare providers. Quickly evaluate protocol feasibility, identify and recruit viable candidates for trials, and track enrolled patients. Download now.
Leveraging analytics using patients’ real-time longitudinal laboratory results, and claims data, yielded higher value information and new revenue streams for TriCore. Read case study on increasing the value of clinical labs for care teams and payers across the continuum of care.
Today’s healthcare data fails to capture the full diversity of interactions patients have with the healthcare system, leading to incomplete information that can put patients at risk. If healthcare is going to achieve optimal outcomes for patients, data must be representative and complete in order to power the highest value applications of AI.
This paper explores:
• The current state of Healthcare data and how it’s pointing us in the wrong direction
• Why existing data providers suffer from significant selection and sampling bias
• How we can create the backbone that unifies healthcare data and delivers ground truth
• The importance of complete patient journey data to power high value applications of AI in healthcare
“Biologics manufacturing can be much riskier because it requires far more planning, investment and experienced personnel to carry it out,” says Jennifer Cannon, the new Vice President, Commercial Operations Development at AbbVie Contract Manufacturing. “Biologics are temperature and light sensitive, susceptible to shearing and degradation, and not as durable and robust as small molecules.” It is therefore critical to have the right manufacturing partner to minimize challenges as a therapy moves from discovery to commercialization.
Emergent BioSolutions provides contract manufacturing services for both bulk drug substances and sterile injectable drug products. Our Maryland based manufacturing facilities currently produce over 30 commercial products and support a host of clinical stage programs.
The services we offer include:
- Drug Substance & Drug Product Manufacturing (Clinical & Commercial Scale)
- Single-Use Platform (2L to 4000L Scale)
- Fill/Finish Capabilities
- Vials & Pre-Filled Syringes
- Liquid & Lyophilized products
- Small Molecules & Biologics
Learn how collaboration between Drug Substance chemists and Drug Product formulators on a formulation development strategy can save time, money, and avoid rework. Download the whitepaper here!
ORC International’s report “Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing” explores the causes, consequences, and potential solutions to forecasting challenges specifically related to biopharmaceutical drug substance manufacturing. Download Here.
Read the “HCP Engagement Report” to understand how marketers are evolving HCP engagement to keep pace with the industry’s digital transformation, and which HCP touchpoints and channels are yielding the best results.
How can patient-reported outcomes (PROs) advance healthcare and how can your organization put them to use? This webinar will review PRO reimbursement strategies and how to use PRO data in the post-approval environment. Register now!
This webinar will benefit executives at Biotech and Pharmaceutical companies interested in learning more about 505(b)(2) drug development and how to save time and money while maximizing the value of their drug development program. Register Now!
By shifting to a model that’s driven by market changes and HCP behavior instead of a regimented POA (plan of action) cycle, companies can provide the relevant and timely experiences that HCPs are looking for. Join this webinar to learn more.
Success in transferring a drug product process requires multi-variant thinking. This webinar will consider a product, wherever it is in its lifecycle, and how consistency, planning and communication form the building blocks for success in the manufacturing process transfer.
White paper outlining the key types of cell-based immunotherapies in oncology, as well as the development and commercial outlook for each. Download now.
Join as Diane Hayes, PHD, InCrowd President and Co-founder, reviews the results from the 2019 physician predictions survey and considers the year ahead. Register Now
Catalent can formulate, fill, and package your product into vial, pre-filled syringe, or cartridge injectable formats that are ready-to-use for the patient or healthcare professional. Learn more about Catalent’s Biologics Drug Product capabilities and capacity at its US and Belgium sites.
In this poster, titled Developing a High-Throughput Formulation Development Platform for High-Concentration, Therapeutic Monoclonal Anitbodies, scientists at Catalent Biologics outline a method utilizing a high-throughput, micro-well plate platform to economically screen a mAb in 96 formulations. Download Here.
Catalent’s biologics packaging operations in the US and Belgium offer state-of-the-art, high-speed, automated equipment, as well as configurable packaging solutions to support both clinical and commercial supply. Learn more about Catalent’s device assembly and packaging capabilities for biologics.
How can we reduce our development timelines and costs—make things go faster, for less?
Answering those questions set Vertex on a path to challenge themselves and their vendors to improve speed without sacrificing quality. Attend this webinar to learn how Vertex is reducing database build times by as much as 50% and reliably lock data in 15-18 days.
This webinar will provide a PoV on R&D Operations from notable industry leaders with over 20+ years of experience designing, building and implementing R&D Operations capabilities within our industry. Register Now!
This whitepaper explores how drug companies can take advantage of a variety of Lifecycle Management (LCM) strategies that prolong intellectual ownership of their innovative therapies while simultaneously allowing them to expand the ways their drug can address currently unmet patient needs. Download now.
Each year, PwC's Health Research Institute (HRI) names the top issues for the health industry in the coming year. What made the list for 2019? Join HRI for a discussion of the most important trends for providers, insurers, pharma/life sciences and employers.
This survey examines the life sciences industry’s progress in reducing system and process complexity to improve study execution. This research aims to understand the drivers, benefits, and barriers of a unified clinical operating model.
Please take a moment to share your thoughts in this 15-minute survey.
This executive summary of a recent industry poll conducted by Seismic, the importance of sales enablement tools becomes clearer, as well as an apparent disconnect between understanding, implementation and measuring success of sales enablement programs within an organization. Learn more.
Join Joe Lipari, Director of Cloud Products at Systech, and special guest Peter Bryant, COO of FarmaTrust, as they explore the path to the future -- from compliance beyond the barcode to the blockchain-enabled pharmaceutical supply chain. Register now.
Join this webinar and explore how science and technology advances are providing unprecedented opportunity to change traditional ways of working in the life sciences industry from early drug develop through to commericalization. The healthcare landscape is changing; it’s never been more human. Maximize the value of digitization within your organization.
This webinar will explore both Right-to-Try legislation and existing Expanded Access Programs, including:
- Understanding sponsor responsibilities under these programs and when products may be eligible for these program
- Evaluating options such as treatment protocols, treatment INDs, and emergency use
- Discussing development risks associated with participation in these programs
In response to an increasing market demand, Cambrex has invested in a Continuous Flow Center enabling development of previously unfeasible process steps. Register for the Cambrex webinar on Continuous Flow Chemistry for APIs and Intermediates today.
This webinar will benefit executives at Biotech and Pharmaceutical companies interested in learning more about 505(b)(2), the pathway of choice. When executed properly, this regulatory pathway enables a lower cost, lower risk, and faster path to approval and market. Register Now!
Tying content to revenue and proving its ROI can be difficult. Join the webinar to learn why understanding content analytics is so important to medical device marketers, what metrics you should be tracking, and how sales enablement can help tie content to revenue. Register now!
Join Cardinal Health experts in the second of our three-part webinar series, as we review the qualitative phase of PRO instrument development within the context of an individual drug development program, PRO instrument modification and regulatory requirements associated with development of these measures for specific populations. Register now!
Modernizing manufacturing equipment, processes, and infrastructure with the newest technology has become a focus to improve their efficiency and overall bottom line. Attend this webinar and learn how to utilize connected IoT devices and data analytics to optimize manufacturing processes, novel ways to use machine learning technology in the cloud, and more.
Join us to hear Steve Gens, managing partner at Gens and Associates, provide real-world examples for each step and guidance on how to justify making these changes within your organization. This webinar will outline five actionable steps to help you establish roles and responsibilities, institute key processes, and improve long-term outcomes. Register Now!
This webinar introduces a QSP model of targeted anabolic growth factors for intra-articular injection for the treatment of diseased joints that was used to systematically map out drug- and target-parameter space to:
- Identify tradeoffs between target and drug properties
- Maximize therapeutic window and tissue targeting
- Identify key missing data
Learn how to use advanced tools and technologies, such as natural language processing, to identify macro and micro healthcare market trends in the US, detect patterns in clinical trial protocol deviations, and discern patterns in patient sentiment, compliance, routines, behaviors, and overall treatment satisfaction and outcomes.
This webinar will examine the effect of technology advancements on the future responsibilities of clinical data managers and discusses the needs introduced by the application of new technologies and broader data source availability.
This webinar will discuss several capsule formulations used in DPIs and will compare their performance, an overview on some of the novel methods being employed to evaluate the physical characteristics and mechanical properties of capsules, and the factors influencing the aerosolisation performance of different capsule types. Register now!
Clinical research and biobanking industries are rapidly adopting eConsent as an alternative to paper. Learn how eConsent can provide patients with clear and easy-to-understand clinical trial information, improve patient compliance, reduce inspection finding, and enable process efficiencies. Register now!
Download this FREE infographic for comparative data and valuable insider insights on newly approved drugs that pharma companies should consider for their products and marketing strategies.
Using a holistic approach to selecting and testing primary packaging and delivery systems can help pharmaceutical manufacturers mitigate particulate risk. Join West experts to learn how a holistic approach to drug product packaging, testing and evaluation can help reduce risk and overcome challenges associated with particulate. Register now!
It has been and big year for gene therapy. This webinar will review Commissioner Gottlieb’s statement, provide an overview of the six guidance documents, and discuss the implications for development of new gene therapy products from the perspective of regulatory strategy, clinical development, pharmacology/toxicology considerations, and CMC development.
Every day, 2.5 quintillion bytes of data are created; 1/3 of that data is healthcare-related. Given the amount of information “noise” in the market, a new NPP landscape has emerged. HCPs now take initiative to source the information they need, when and where they want it (particularly in light of reduced rep access). Register Now!
Download this FREE infographic for comparative data and valuable insider insights that pharma companies should consider for their products and marketing strategies.
Watch this webinar to hear from Bryan Knox on reliable approaches that have supported hundreds of small and virtual companies help build value to their lead candidates in early phases of development as well as help accelerate the development process to overcome formulation challenges. Register to watch on-demand.
Life sciences companies are embracing the essential roles that real world data (RWD) and the generation of real world evidence (RWE) play in the development of new treatments for patients.
This whitepaper will explore three areas where RWD and RWE are being applied to improve the design and execution of clinical studies. Download now to learn more.
Join this webinar to discover how ZipDose® by Aprecia enables a new world of powerful formulation solutions for NCE product candidates in Phase I or Phase II development and testing. You’ll also review how 3DP can offer formulation advantages such as better molecule protection, adjustable powder layers and flexibility in dose loading for adaptive clinical trials.
Manufacturing is one of the most challenging environments in the pharmaceutical industry. This whitepaper discusses how new data acquisition and analytic technologies can boost manufacturing intelligence and agility, how companies like Merck and Moderna optimize manufacturing operations utilizing the cloud, and more. Download it now!
Learn how top pharmas and CROs plan to speed database build and data collection, as well as their top challenges and future priorities. This in-depth research from Tufts follows their industry-wide eClinical Landscape Study, examining the major cause of database build delays and their impact on trial cycle times. Register Now
Considering oncology drug development and clinical trial for Asia market? Join the experts from CMIC Group, the largest CRO in Japan, to learn the insights on how to start your early oncology drug development and ensure clinical trial success. Register now!